Dr. Cavanaugh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-936-2000
Education & Training
- Johns Hopkins UniversityFellowship, Nephrology, 2002 - 2003
- Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
- Yale School of MedicineClass of 1999
Certifications & Licensure
- TN State Medical License 2006 - 2025
- MD State Medical License 2003 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Targeting Social Determinants to Improve Chronic Kidney Disease Care Start of enrollment: 2012 May 01
- Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial Start of enrollment: 2013 Nov 01
- HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis Start of enrollment: 2021 Jan 03
Publications & Presentations
PubMed
- 265 citationsAssociation of numeracy and diabetes controlKerri L. Cavanaugh, Mary Margaret Huizinga, Kenneth A. Wallston, Tebeb Gebretsadik, Ayumi Shintani
Annals of Internal Medicine. 2008-05-20 - 63 citationsSafety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.David M. Charytan, Jonathan Himmelfarb, T. Alp Ikizler, Dominic S. Raj, Jesse Y. Hsu
Kidney International. 2019-04-01 - 33 citationsOral protein supplementation alone improves anabolism in a dose-dependent manner in chronic hemodialysis patients.Mary B. Sundell, Kerri L. Cavanaugh, Pingsheng Wu, Ayumi Shintani, Raymond M. Hakim
Journal of Renal Nutrition. 2009-09-01
Press Mentions
- ASN Names Recipients of Mentorship, Researcher AwardsNovember 5th, 2021
- Quantifying Risk Tolerance Among Potential Living Kidney Donors with the Donation-Specific Risk QuestionnaireJanuary 25th, 2021
- Kidney Function Tests: Purpose, Types and ProcedureMay 21st, 2020
- Join now to see all
Grant Support
- Facilitating Anemia Treatment Risk Communication For Patients With Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2012
- Addressing Literacy And Numeracy In Self-Care &Clinical Outcomes In ESRDNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: